4
Clinical Trials associated with ICX RHYA prospective placebo controlled phase II study to evaluate ICX-RHY-013 for the treatment of skin erosions in dystrophic epidermolysis bullosa patients
A Phase I/II Clinical Study of Allogeneic Human Dermal Fibroblasts for Remodeling Scar Contractures
The primary objective of this study is to evaluate the safety of ICX-RHY-013 in the treatment of stable, restrictive scars in subjects who have suffered a burn injury. Evaluation will be achieved through regular assessment of adverse events, vital signs, blood work monitoring and laboratory analysis cellular properties of the scar through biopsy.
The secondary objectives of this study are to evaluate improvement in symptoms of scars including reduced pain, discomfort and itching, improvement in mobility and daily function, improvement in appearance and scar texture.
A phase IIa open-label study using ICX-RHY to enhance the aesthetic appearance of facial skin imperfections. - The Enhance Trial
100 Clinical Results associated with ICX RHY
100 Translational Medicine associated with ICX RHY
100 Patents (Medical) associated with ICX RHY
100 Deals associated with ICX RHY